Global Health

who.int

23 DECEMBER 2016 | GENEVA - An experimental Ebola vaccine was highly protective against the deadly virus in a major trial in Guinea, according to results published today in The Lancet. The vaccine is the first to prevent infection from one of the most lethal known pathogens, and the findings add weight to early trial results published last year.

The vaccine, called rVSV-ZEBOV, was studied in a trial involving 11 841 people in Guinea during 2015. Among the 5837 people who received the vaccine, no Ebola cases were recorded 10 days or more after vaccination. In comparison, there were 23 cases 10 days or more after vaccination among those who did not receive the vaccine.

The trial was led by WHO, together with Guinea’s Ministry of Health and other international partners.

(READ COMPLETE ARTICLE)

CLICK HERE - The Lancet - Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)

Juan Pedro, who has microcephaly and turned one-year-old on December 4, sits in a specially designed chair to keep him upright as he is kissed by his sister Jennifer Karine on December 12, 2016 in Recife, Brazil. As many of the babies with microcephaly, believed to be linked to the Zika virus, turn one-year-old in Recife, doctors and mothers are adapting and learning treatments to assist and calm the children. Many of the children are suffering a plethora of difficulties including vision and hearing problems with doctors now labeling the overall condition as 'Congenital Zika Syndrome'. (Photo by Mario Tama/Getty Images)

CLICK HERE - STUDY - NEJM - Zika Virus Infection in Pregnant Women in Rio de Janeiro

forbes.com - by Tara Haelle - December 14, 2016

The rate of birth defects, disability and brain irregularities in babies exposed to the Zika virus is considerably higher than was previously believed — regardless of the mother’s symptoms or the trimester she had the infection — found a new study . . .

FLICKR, RIKKISREFUGE

CLICK HERE - STUDY - Carbapenemase-producing Enterobacteriaceae recovered from the environment of a swine farrow-to-finish operation in the United States

Evidence of resistance to a “last-resort” drug for antibiotic-resistant bacteria is discovered among farm animals for the first time.

the-scientist.com - by Ben Andrew Henry - December 7, 2016

Modern agriculture relies on antibiotics to shield livestock from disease, but widespread over-use of antibiotics has raised concerns over creating highly resistant “superbugs.” Researchers announced this week (December 5) that bacteria carrying a rare, dangerous gene for antibiotic resistance have been found in agricultural animals for the first time.

In a study published in Antimicrobial Agents and Chemotherapy, researchers took swabs and fecal samples from a pig farm and discovered bacteria resistant to carbapenems, an important class of antibiotics.

(READ COMPLETE ARTICLE)

submitted by John Carroll

un.org

30 November 2016 – The response to cholera in Haiti will be a “long and thorough battle,” but the United Nations will stand by the Haitian people and authorities, Stéphane Dujarric, the Spokesman for the Secretary-General, on the eve of the launch of the Organization's new approach to tackling the epidemic in the country.

The new approach was announced last August and will be launched by Secretary-General Ban Ki-moon to the UN General Assembly on Thursday, 1 December. It includes rapid interventions in areas where cases are reported and the prevention of future high-risk public health crises.

The new approach on cholera also focuses on people and proposes the establishment of a program of material assistance and support to Haitians directly affected by the disease.

(READ COMPLETE ARTICLE)